Virtual Library

Start Your Search

  • WCLC 2015

    16th World Conference on Lung Cancer

    Access to all presentations that occur during the 16th World Conference on Lung Cancer in Denver, Colorado

    Presentation Date(s):  
    • September 6 - 9, 2015
    • Total Presentations: 2499

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

Filter Results:

Show Only Available Presentations

  • +

    ORAL 06 - Next Generation Sequencing and Testing Implications

    • Type: Oral Session
    • Track: Biology, Pathology, and Molecular Testing
    • Presentations: 9
    • Moderators:G. De Lima Lopes
    • Coordinates: 9/07/2015, 10:45 - 12:15, Mile High Ballroom 1a-1f
  • +

    ORAL 10 - SCLC

    • Type: Oral Session
    • Track: Small Cell Lung Cancer
    • Presentations: 9
    • Moderators:C. Faivre-Finn
    • Coordinates: 9/07/2015, 10:45 - 12:15, 605+607
    • +

      ORAL10.01 - A DLL3-Targeted ADC, Rovalpituzumab Tesirine, Demonstrates Substantial Activity in a Phase I Study in Relapsed and Refractory SCLC

      11:05 - 11:16  |  Author(s): C.M. Rudin

      • Abstract

      Loading...

  • +

    P2.01 - Poster Session/ Treatment of Advanced Diseases – NSCLC

    • Type: Poster
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 102
    • Coordinates: 9/08/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
    • +

      P2.01-004 - Oncologists' Comprehension and Beliefs Surrounding Cancer Immunotherapy in Advanced NSCLC

      09:30 - 09:30  |  Author(s): T. Herrmann

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    ORAL 20 - Chemoradiotherapy

    • Type: Oral Session
    • Track: Treatment of Locoregional Disease – NSCLC
    • Presentations: 7
    • Moderators:G. Blumenschein
    • Coordinates: 9/08/2015, 10:45 - 12:15, 201+203
    • +

      ORAL20.02 - Safety Results of the Consolidation Phase of a Phase III (PROCLAIM): Pemetrexed, Cisplatin or Etoposide, Cisplatin plus Thoracic Radiation Therapy followed by Consolidation Cytotoxic Chemotherapy in Locally Advanced Nonsquamous Non-Small Cell Lung Cancer

      10:56 - 11:07  |  Author(s): R. Govindan

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MS 16 - Novel SCLC Therapies

    • Type: Mini Symposium
    • Track: Small Cell Lung Cancer
    • Presentations: 7
    • Moderators:C. Barrios
    • Coordinates: 9/08/2015, 14:15 - 15:45, Mile High Ballroom 4a-4f
    • +

      MS16.06 - New Chemotherapies (Eribulin, Aldoxorubicin, Etirinotecan, MM398)

      15:25 - 15:38  |  Author(s): R. Govindan

      • Abstract
      • Presentation

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P3.01 - Poster Session/ Treatment of Advanced Diseases – NSCLC

    • Type: Poster
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 91
    • Coordinates: 9/09/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
    • +

      P3.01-089 - Nab-Paclitaxel with or without CC-486 as Second-Line Therapy for NSCLC (ABOUND.2L)

      09:30 - 09:30  |  Author(s): R. Govindan

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    ORAL 33 - ALK

    • Type: Oral Session
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 8
    • Moderators:S. Gadgeel
    • Coordinates: 9/09/2015, 16:45 - 18:15, Mile High Ballroom 1a-1f